These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 991147)

  • 21. [Acute promyelocytic leukemia: confirmation of the therapeutic value of the cytosine arabinoside-thioguanine combination].
    Monica C; Cucinotta D; Carapezzi C; Ceccato S
    G Clin Med; 1976; 57(5-6):192-9. PubMed ID: 1070455
    [No Abstract]   [Full Text] [Related]  

  • 22. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
    Wolff SN; Herzig RH; Phillips GL; Lazarus HM; Greer JP; Stein RS; Ray WA; Herzig GP
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):12-7. PubMed ID: 3589687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experiences in the treatment of acute myeloblastic leukemia and acute monocytic leukemia using cytosine arabinoside and 6-thioguanine].
    Essers U; Althof S; Ewers M
    Verh Dtsch Ges Inn Med; 1975; 81():1126-8. PubMed ID: 1065154
    [No Abstract]   [Full Text] [Related]  

  • 24. Study of cytosine arabinoside (NSC-63878) synchronization plus vincristine (NSC-67574), prednisone (NSC-10023), and L-asparaginase (NSC-109229) for remission induction in advanced acute leukemia in children.
    Sutow WW; Thomas D; Steuber CP; Pullen J; Vats T; Bryan JH; Morgan SK
    Cancer Treat Rep; 1976 May; 60(5):591-4. PubMed ID: 991148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Etoposide in combination with cytarabine, doxorubicin, and 6-thioguanine for treatment of acute nonlymphoblastic leukemia in a protocol adjusted for age.
    Bern MM; Wallach SR; Arkin CF; Lokich JJ; Huberman MS; Anderson NR; Corkery JC; Paul SD; Phillips DF; Sonneborn HA
    Cancer Treat Rep; 1987 Feb; 71(2):201-3. PubMed ID: 3802115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [High doses of cytosine arabinoside in the treatment of patients with acute relapsing or refractory leukemia].
    Lobato-Mendizábal E; Ruiz-Argüelles GJ; Marín-López A
    Rev Invest Clin; 1989; 41(2):139-45. PubMed ID: 2675236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [High-dose cytosine arabinoside treatment of leukemia with special reference to the optimal number of doses].
    Sampi K; Maseki N; Kumai R; Kaneko Y; Sakurai M; Hattori M
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2595-8. PubMed ID: 2774589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of adult acute non-lymphocytic leukemia.
    Gray JL; Robinson WA
    Rocky Mt Med J; 1975 Jan; 72(1):13-6. PubMed ID: 1111047
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of acute nonlymphocytic leukemia (ANLL) in elderly patients. Results of a multicentric study.
    Mandelli F; Amadori S; Fabiani F; Grignani F; Liso V; Martelli M; Neri A; Petti MC; Tonato M
    Haematologica; 1979 Jun; 64(3):331-8. PubMed ID: 113301
    [No Abstract]   [Full Text] [Related]  

  • 30. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
    Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R;
    Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged maintained remissions of adult acute non-lymphocytic leukaemia.
    Peterson BA; Bloomfield CD
    Lancet; 1977 Jul; 2(8030):158-60. PubMed ID: 69780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
    Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
    [No Abstract]   [Full Text] [Related]  

  • 33. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.
    Presant CA; Berger NA; Klahr C; Phillips GL
    Cancer; 1980 Jul; 46(1):22-8. PubMed ID: 6930320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of treating acute nonlymphoblastic leukaemia in adults (author's transl)].
    Hossfeld DK; Faltermeier MT; Schmidt CG
    Dtsch Med Wochenschr; 1979 Nov; 104(45):1595-9. PubMed ID: 498989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Difficulties of remission induction treatment of acute myeloblastic leukemia].
    Fière D; Bryon PA; Martin C; Revol L
    Sem Hop; 1974 May; 50(25):1691-4. PubMed ID: 4369538
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mitoxantrone and conventional-dose cytosine arabinoside for relapsed and refractory acute leukemia].
    Wakita A; Murase T; Uchida T; Fujiwara Y; Tanaka M; Ohkita T
    Gan To Kagaku Ryoho; 1992 May; 19(5):653-7. PubMed ID: 1580638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The results of treatment with idarubicin in childhood acute nonlymphoblastic leukemia.
    Saşmaz I; Tanyeli A; Bayram I; Antmen B; Yilmaz L; Küçükosmanoğlu O; Kilinç Y
    Turk J Pediatr; 2004; 46(1):32-7. PubMed ID: 15074372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment results of therapy resistant acute leukemias with 7 cystostatic agents (TRAMPCO-scheme)].
    Hartwich G; von Roemeling R; Neidhardt B
    Med Klin; 1978 Sep; 73(39):1356-9. PubMed ID: 703661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remission maintenance of acute nonlymphoblastic leukemia with BCNU (NSC-409962) and cyclophosphamide (NSC-26271).
    Manaster J; Cowan DH; Curtis JE; Hasselback R; Bergsagel DE
    Cancer Chemother Rep; 1975; 59(3):537-45. PubMed ID: 1060509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytarabine and thioguanine for acute nonlymphocytic leukemia. Another look.
    Saponara EJ; Rothenberg SP; Villamena D
    Arch Intern Med; 1979 Nov; 139(11):1277-80. PubMed ID: 292356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.